Won’t Rush Covid-19 Vaccine Under Pressure, Says Bharat Biotech CMD

Like
Like Love Haha Wow Sad Angry

Covaxin Enter Phase Two Trial – Safety And Quality Will Be Paramount The phase-I clinical trials of the COVID-19 vaccine developed by Hyderabad-based pharma firm- Bharat Biotech has completed. Its chairman Krishna Ella said they cannot rush the procedure of vaccine development while claiming that the company would not succumb to pandemic pressure. During an […]

The post Won’t Rush Covid-19 Vaccine Under Pressure, Says Bharat Biotech CMD appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/08/covaxin-enter-phase-two-trial-safety-and-quality-will-be-paramount/

Like
Like Love Haha Wow Sad Angry